| Dr Samir R Yahia, MD | |
|
50505 Schoenherr Rd Ste 175, Shelby Township, MI 48315 | |
| (586) 630-5421 | |
| (586) 488-1934 |
| Full Name | Dr Samir R Yahia |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 56 Years |
| Location | 50505 Schoenherr Rd Ste 175, Shelby Township, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780731075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 4301033689 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St John Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension St John Hospital | 3173424082 | 296 |
News Archive
Brain tumor experts at Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center have launched a revolutionary fast-track approach to cancer research, giving new hope to brain cancer patients.
Bioengineers from the University of California, San Diego developed an explanation for why some types of neurons die sooner than others in the brains of people with Alzheimer's disease. These insights, published in the journal Nature Biotechnology on November 21, come from detailed models of brain energy metabolism developed in the Department of Bioengineering at the UC San Diego Jacobs School of Engineering.
Single nucleotide polymorphisms (SNPs) are DNA sequence variations that occur when a single nucleotide in the genome sequence is altered. Prior research suggested an association between SNPs in a gene that encodes aspects of the brain's gamma-amino butyric acid (GABA)-A receptors (the GABRA2 gene) and alcohol dependence. A study of responses to the aromas of alcoholic drinks according to subjects' genotyping at a SNP in GABRA2 has found that this genotype can affect the brain's reward responses to cues such as alcohol odors.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces final positive results of its pivotal phase III clinical study in immunocompetent patients with recurrent herpes labialis (LIP Study) treated with acyclovir Lauriad®. Primary and secondary endpoints have been met with marked efficacy and good tolerance.
› Verified 1 days ago
| Entity Name | Ascension St John Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043478910 PECOS PAC ID: 3173424082 Enrollment ID: O20040115000409 |
News Archive
Brain tumor experts at Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center have launched a revolutionary fast-track approach to cancer research, giving new hope to brain cancer patients.
Bioengineers from the University of California, San Diego developed an explanation for why some types of neurons die sooner than others in the brains of people with Alzheimer's disease. These insights, published in the journal Nature Biotechnology on November 21, come from detailed models of brain energy metabolism developed in the Department of Bioengineering at the UC San Diego Jacobs School of Engineering.
Single nucleotide polymorphisms (SNPs) are DNA sequence variations that occur when a single nucleotide in the genome sequence is altered. Prior research suggested an association between SNPs in a gene that encodes aspects of the brain's gamma-amino butyric acid (GABA)-A receptors (the GABRA2 gene) and alcohol dependence. A study of responses to the aromas of alcoholic drinks according to subjects' genotyping at a SNP in GABRA2 has found that this genotype can affect the brain's reward responses to cues such as alcohol odors.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces final positive results of its pivotal phase III clinical study in immunocompetent patients with recurrent herpes labialis (LIP Study) treated with acyclovir Lauriad®. Primary and secondary endpoints have been met with marked efficacy and good tolerance.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samir R Yahia, MD 133 S Main St, Mount Clemens, MI 48043-2308 Ph: (586) 329-1880 | Dr Samir R Yahia, MD 50505 Schoenherr Rd Ste 175, Shelby Township, MI 48315 Ph: (586) 630-5421 |
News Archive
Brain tumor experts at Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center have launched a revolutionary fast-track approach to cancer research, giving new hope to brain cancer patients.
Bioengineers from the University of California, San Diego developed an explanation for why some types of neurons die sooner than others in the brains of people with Alzheimer's disease. These insights, published in the journal Nature Biotechnology on November 21, come from detailed models of brain energy metabolism developed in the Department of Bioengineering at the UC San Diego Jacobs School of Engineering.
Single nucleotide polymorphisms (SNPs) are DNA sequence variations that occur when a single nucleotide in the genome sequence is altered. Prior research suggested an association between SNPs in a gene that encodes aspects of the brain's gamma-amino butyric acid (GABA)-A receptors (the GABRA2 gene) and alcohol dependence. A study of responses to the aromas of alcoholic drinks according to subjects' genotyping at a SNP in GABRA2 has found that this genotype can affect the brain's reward responses to cues such as alcohol odors.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces final positive results of its pivotal phase III clinical study in immunocompetent patients with recurrent herpes labialis (LIP Study) treated with acyclovir Lauriad®. Primary and secondary endpoints have been met with marked efficacy and good tolerance.
› Verified 1 days ago
Dr. Julia Tesch, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 50505 Schoenherr Rd, Suite 340, Shelby Township, MI 48315 Phone: 586-731-8400 Fax: 526-731-8406 | |
Sima Salahie, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 50505 Schoenherr Rd Ste 340, Shelby Township, MI 48315 Phone: 586-731-8400 Fax: 586-731-8406 | |
Luay Sayed, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 49050 Schoenherr Rd Ste 100, Shelby Township, MI 48315 Phone: 586-566-7870 Fax: 586-566-7850 | |
Paul K Fozo, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 50505 Schoenherr Rd, Suite 340, Shelby Township, MI 48315 Phone: 586-731-8400 Fax: 586-731-8406 | |
Bryan G Barnosky, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 50505 Schoenherr Rd, Suite 290, Shelby Township, MI 48315 Phone: 586-314-0080 Fax: 586-731-6257 | |
Saurabh Gandhi, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 45640 Schoenherr Rd, Suite B, Shelby Township, MI 48315 Phone: 586-247-4300 Fax: 586-532-6496 | |
Dr. Steven M Taormina, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 50505 Schoenherr Rd, Suite 300, Shelby Township, MI 48315 Phone: 586-726-5566 Fax: 586-726-8085 |